MUNNIRPALLAM MADHU SUNDAR SUBRAMANIAN
Transaction: 04/01/2026
OTHER
Change
0
Price
Not reported
Filing
04/10/2026
Type
OTHER
Dr. Reddy's Laboratories Limited
RDY • Drug Manufacturers - Specialty & Generic
$11.97
— 0.00 (0.00%)
EarningsLatest report: Mar 31, 2026
FAVORABLE PROFILEAttractiveConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$9.99B
Growth
13.7%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 12.8%Positive revenue growth · 13.2%Positive free cash flow · 38.57Consistent free cash flow · 5/5Manageable debt level · 0.21
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 11, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$11.97
Change0.00%
Shares Out834.80M
Market Cap$9.99B
52W Range12.19 - 15.67
Beta0.26
P/E20.44
P/S2.61
P/B2.49
P/FCF28.71
EV/Sales3.22
EV/EBITDA16.13
Price$11.97
Change0.00%
Shares Out834.80M
Market Cap$9.99B
52W Range12.19 - 15.67
Beta0.26
P/E20.44
P/S2.61
P/B2.49
P/FCF28.71
EV/Sales3.22
EV/EBITDA16.13
EV/FCF35.45
Earnings Yield4.89%
FCF Yield3.48%
Dividend Yield0.76%
Gross Margin52.77%
Oper. Margin13.83%
Profit Margin12.76%
Debt/Eq0.21
Current Ratio1.80
Quick Ratio1.35
Revenue 5Y13.66%
FCF 5Y23.37%
Volume3.00M
Avg Volume2.55M
EPS Surprise-0.03
Investment DNA
How strong this company looks for long-term investors
81
out of 100
Business Quality
Margins, moat, returns
74/100
Financial Strength
Debt, cash, stability
91/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
63/100
Why this score▼
Stable or improving margins · 12.8%Positive revenue growth · 13.2%Positive free cash flow · 38.57Consistent free cash flow · 5/5Manageable debt level · 0.21Healthy liquidity · 1.8
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 12 analyst votes · 2026-09-05
67/100
Neutral
Bullish
6
Hold
4
Bearish
2
Insider Transactions
Recent executive and insider activity
Seth Alpna
Transaction: 12/18/2025
OTHER
Change
0
Price
Not reported
Filing
04/01/2026
Type
OTHER
SAPRA DEEPAK
Transaction: 12/18/2025
OTHER
Change
0
Price
Not reported
Filing
04/01/2026
Type
OTHER
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| MUNNIRPALLAM MADHU SUNDAR SUBRAMANIAN | OTHER | 0 | Not reported | 04/01/2026 | 04/10/2026 |
| Seth Alpna | OTHER | 0 | Not reported | 12/18/2025 | 04/01/2026 |
| SAPRA DEEPAK | OTHER | 0 | Not reported | 12/18/2025 | 04/01/2026 |
| MANNAM VENKATA NARASIMHAM | OTHER | 0 | Not reported | 12/18/2025 | 04/01/2026 |
| BHETHANABOTTLA SRINIVASA PHANIMITRA | OTHER | 0 | Not reported | 12/18/2025 | 04/01/2026 |
| KULKARNI SUSHRUT | OTHER | 0 | Not reported | 12/18/2025 | 04/01/2026 |
| VENKATESH KRISHNA | OTHER | 0 | Not reported | 12/18/2025 | 04/01/2026 |
| Israeli Erez | OTHER | 0 | Not reported | 12/18/2025 | 04/01/2026 |
| MOTUPALLI VENKATA RAMANA | OTHER | 0 | Not reported | 12/18/2025 | 04/01/2026 |
| KALAWADIA MILAN KANTILAL | OTHER | 0 | Not reported | 12/18/2025 | 04/01/2026 |
| AGHANIAN PATRICK RUDOLF | OTHER | 0 | Not reported | 12/18/2025 | 04/01/2026 |
| KUMAR ARUN MADHAVAN | OTHER | 0 | Not reported | 12/18/2025 | 03/27/2026 |
| PURI LEO | OTHER | 0 | Not reported | 12/18/2025 | 03/27/2026 |
| KODUMUDI PRANATHARTHI HARAN KRISHNAN | OTHER | 0 | Not reported | 12/18/2025 | 03/27/2026 |
| WAN PENNY CHAN | OTHER | 0 | Not reported | 12/18/2025 | 03/27/2026 |
| MEHTA SANJIV SOSHIL | OTHER | 0 | Not reported | 12/18/2025 | 03/27/2026 |
| SHARMA SHIKHA SANJAYA | OTHER | 0 | Not reported | 12/18/2025 | 03/27/2026 |
| Prasad G V | OTHER | 0 | Not reported | 12/18/2025 | 03/20/2026 |
| Reddy K Satish | OTHER | 0 | Not reported | 12/18/2025 | 03/20/2026 |